Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
about
The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report.Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in ratPrediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties.Evaluation of toxicogenomics approaches for assessing the risk of nongenotoxic carcinogenicity in rat liverDiscrimination of carcinogens by hepatic transcript profiling in rats following 28-day administrationCombining QSAR Modeling and Text-Mining Techniques to Link Chemical Structures and Carcinogenic Modes of ActionUse of high-throughput RT-qPCR to assess modulations of gene expression profiles related to genomic stability and interactions by cadmiumZBIT Bioinformatics Toolbox: A Web-Platform for Systems Biology and Expression Data Analysis.Novel Uses of In Vitro Data to Develop Quantitative Biological Activity Relationship Models for in Vivo Carcinogenicity Prediction.Stem cell proliferation patterns as an alternative for in vivo prediction and discrimination of carcinogenic compounds.Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells.Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.ToxDBScan: Large-scale similarity screening of toxicological databases for drug candidatesAlternatives models in carcinogenicity testing--a European perspective.Improving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animals.Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findingsEpigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy.Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents.The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research.Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotion.Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.Preclinical risk assessment of drug-induced hypo- and hyperprolactinemia.A critical assessment of the methodologies to investigate the role of inhibition of apoptosis in rodent hepatocarcinogenesis.Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties.Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective.Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.Identification of specific mRNA signatures as fingerprints for carcinogenesis in mice induced by genotoxic and nongenotoxic hepatocarcinogens.Distinguishing between genotoxic and non-genotoxic hepatocarcinogens by gene expression profiling and bioinformatic pathway analysis.In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals.Gene expression dose-response of liver with a genotoxic and nongenotoxic carcinogen.Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose.An integrative test strategy for cancer hazard identification.Renal tumors in male rats following long-term administration of bazedoxifene, a tissue-selective estrogen receptor modulator.Raf inhibition causes extensive multiple tissue hyperplasia and urinary bladder neoplasia in the rat.
P2860
Q25256724-73CDD14C-63F3-4650-8763-D14DB55AA661Q27332037-9E289183-A653-47B7-AF45-108B9D777640Q27690887-C3A87E67-DF7F-49D6-B879-65DD66623DDDQ28538823-9B52478A-D4CB-4B00-9C96-9A9E401E3310Q28574209-3DD79BEA-6E05-456C-99C9-6225542DFA34Q28596871-D247C9CF-3952-41E4-828C-05B4B7F8CE38Q28821954-747B3322-F447-4EF1-8ECF-F40A3D320B00Q31046381-44FB5173-7B0E-4EB0-A4A0-5190F5AA29C1Q31119555-E744CDFD-F68B-4145-B63C-45BFE43ABDD2Q33628796-3972A3FE-A5E6-42CB-AEA8-18F286834A1AQ34006474-D4EAF335-A543-4CEB-9FF9-C69233C51886Q34181630-0B81BBED-6173-4AA5-B5DA-0C3C4FCC8411Q34487014-874D07A9-F940-4230-9052-4E218183A90DQ34560260-97351C2A-654B-4EE7-A1CD-E3C7E954025DQ35244653-BEF6ABA5-A613-4ACD-9889-4C147E4DB540Q35603973-7C78C131-B43F-4244-BE49-695D471D4177Q36202782-0E1AEB0D-028A-4E8B-94EB-0A9682775D8CQ36846075-4BBD99F1-9010-4B1A-9E8D-AE8CD78426FEQ36945640-569B8495-2C36-40D0-A809-8614A66A8CDDQ37695280-2184A982-E5D8-4962-B412-41AEAFC8458BQ37701274-A32A08AD-C80C-47F5-8E2E-2F2CBA4300C2Q37865527-4B04897C-B306-4206-BAA5-2204BC7CD693Q37925692-B8032464-48BF-4B61-A56D-BDEC8FF35288Q38327212-AB98F496-8C48-48DD-A3FD-51B49D6AF095Q38818082-66F28B5D-CF6E-4C15-B5C1-83959CC55EC9Q38822857-A2C06C1D-87A8-41D1-A6EC-29D3180692CDQ39736029-E6A35BAA-EF84-4D1B-901F-1B141D747424Q43550464-C8C10CE5-64C3-45CF-8CF2-8FAC005F8D67Q45423052-8068CCDF-19D0-4E90-ABD0-708CF6F71E5BQ45911936-2F7D1A3A-077D-4AE6-8681-B19A09C62F5FQ46970658-F84F0CF3-581E-4120-9078-E38FDCB1BD15Q47325378-2DEFC5CB-A1FB-444A-8A89-F146D61A7967Q50856445-CAA369AD-FFFA-4DEA-A826-6A044FE9E371Q51273068-0D050093-6245-4BCF-BC3B-8815DA7BB3FBQ51449752-3E25BE50-7962-4648-B5BF-3E0712E631F3
P2860
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
@ast
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
@en
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
@nl
type
label
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
@ast
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
@en
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
@nl
prefLabel
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
@ast
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
@en
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
@nl
P356
P1476
Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard
@en
P2093
Van der Laan JW
P304
P356
10.1006/RTPH.2000.1427
P407
P577
2000-10-01T00:00:00Z